...
首页> 外文期刊>Clinical and diagnostic laboratory immunology >Neutralizing antibodies against autologous human immunodeficiency virus Type 1 isolates in patients with increasing CD4 cell counts despite incomplete virus suppression during antiretroviral treatment.
【24h】

Neutralizing antibodies against autologous human immunodeficiency virus Type 1 isolates in patients with increasing CD4 cell counts despite incomplete virus suppression during antiretroviral treatment.

机译:在抗逆转录病毒治疗期间病毒抑制不完全的情况下,CD4 细胞计数增加的患者中和针对自体人类免疫缺陷病毒 1 型分离株的中和抗体。

获取原文
获取原文并翻译 | 示例
           

摘要

Antiretroviral-treated human immunodeficiency virus (HIV) type 1-seropositive individuals can remain clinically stable for a long period of time with an increasing CD4 cell count irrespective of incomplete viral suppression. We evaluated the role of neutralizing antibody (NtAb) activity in the etiopathogenesis of this viro-immunological disconnection (defined as an increasing CD4(+)-cell count despite a persistent, detectable viral load during antiretroviral therapy) in 33 patients failing therapy with two analogue nucleoside reverse transcriptase inhibitors. An HIV NtAb titer of >/=1:25 was detected in specimens from 16 out of 33 (48) patients. A significant correlation was found between NtAb titers and CD4(+)-cell counts (P = 0.001; r = 0.546) but not with HIV RNA levels in plasma. Five patients with a viro-immunological disconnection had an NtAb titer of >1:125, statistically higher than the NtAb titers for the remaining 28 patients with both virologic and immunologic failure (P < 0.0001). The HIV-specific humoral immune response could play a role during antiretroviral treatment to improve immunological function despite an incomplete suppression of viral load.
机译:抗逆转录病毒治疗的人类免疫缺陷病毒 (HIV) 1 型血清阳性个体可以长期保持临床稳定,CD4 细胞计数增加,无论病毒抑制是否不完全。我们评估了中和抗体(NtAb)活性在33例使用两种类似物核苷逆转录酶抑制剂治疗失败的患者中,在这种病毒免疫学断开(定义为尽管在抗逆转录病毒治疗期间持续存在可检测到的病毒载量,但CD4(+)细胞计数增加)的病因发病机制中的作用。在 33 例患者中有 16 例 (48%) 的标本中检测到 >/=1:25 的 HIV NtAb 滴度。NtAb滴度与CD4(+)细胞计数(P = 0.001;r = 0.546)之间存在显著相关性,但与血浆中的HIV RNA水平无关。5 例病毒免疫学断开的患者的 NtAb 滴度为 >1:125,统计学上高于其余 28 例病毒学和免疫学失败患者的 NtAb 滴度 (P < 0.0001)。HIV特异性体液免疫反应可能在抗逆转录病毒治疗中发挥作用,以改善免疫功能,尽管病毒载量抑制不完全。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号